Log In
Print this Print this

H7N9 avian influenza vaccine

  Manage Alerts
Collapse Summary General Information
Company Sanofi
DescriptionMonovalent influenza A/H7N9 virus vaccine made with hemagglutinin (HA) antigen derived from the influenza A/Shanghai/2/2013 virus
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPhase II
Standard IndicationInfluenza virus
Indication DetailsVaccinate against H7N9 avian influenza virus infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today